ZOLL MEDICAL CORPORATION ENTERED INTO A TECHNOLOGY PARTNERSHIP WITH INOVISE

698

July 28, 2009—Chelmsford, Mass.,—ZOLL Medical Corporation (Nasdaq GS: ZOLL), announced today that it has entered into a multi-year agreement to license Inovise Medical, Inc.’s AUDICOR® technology.

The AUDICOR technology analyzes heart sounds to provide more diagnostic capabilities, in addition to the ECG alone, to aid in diagnosing acute and occasionally occult heart failure.

“Integrating advanced diagnostic technology into our resuscitation equipment further emphasizes our ongoing commitment to improving all aspects of resuscitation and providing clinicians with the most comprehensive set of technologies available to improve outcomes,” Richard A. Packer, Chairman and Chief Executive Officer of ZOLL, commented.

Peter Bauer, President of Inovise Medical, added, “Our strategy is to deploy our advanced technology through partners and we are pleased that through ZOLL’s successful products, more patients and clinicians will benefit from earlier diagnosis and treatment in the near future.

About Inovise Medical

Inovise Medical, Inc., of Portland, Oregon, is a privately held company founded in 1997, which is focused on advanced cardiac technology. Inovise Medical’s technology includes advanced ECG algorithms for improved MI detection and AUDICOR®, which evaluates the performance of the heart by analyzing heart sounds and cardiac timing intervals.

AUDICOR® enables clinicians to non-invasively and rapidly assess cardiac patients to aid in early diagnosis and/or to adjust treatment. AUDICOR technology is used both in EMS and hospitals for diagnostics and in clinics for managing heart failure therapy. Recent advances of the technology are made in ambulatory monitoring of heart failure patients in aid of differential diagnosis and treatment optimization. Additional information on Inovise Medical, Inc. and AUDICOR® technology may be found at http://www.audicor.com

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation and temperature control therapies for the treatment of critical care patients. With products for pacing, defibrillation, circulation, temperature management, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help® and See-Thru CPR®, which help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. During 2008 ZOLL marked the 25th anniversary of the Company’s resuscitation product development. For more information, visit www.zoll.com

Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forwardlooking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 8, 2009. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

Further Contacts

Investor Contact

A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation +1 (978) 421-9655

Media Contact:

Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637
degan@zoll.com

Copyright © 2009 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, Real CPR Help, and See-Thru CPR are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.